Sirtuin Signaling in Diabetic Kidney Disease

Sirtuins (SIRT1–7) are a family of NAD+-dependent deacetylases that regulate key cellular processes including mitochondrial function, oxidative stress response, autophagy and inflammation. In the context of diabetic kidney disease, aberrant glucose metabolism, persistent oxidative stress and chronic low-grade inflammation converge on renal cells—podocytes, mesangial cells and tubular epithelial cells—leading to fibrosis, proteinuria and progressive loss of renal function. Sirtuin signalling modulates transcription factors such as FOXO, NF-κB and TGF-β mediators to restore homeostasis. For instance, SIRT1 activation promotes autophagic clearance of damaged mitochondria in tubular epithelia, attenuates pro-fibrotic Smad7 acetylation in mesangial cells and suppresses podocyte apoptosis through deacetylation of histone and non-histone substrates. SIRT3 and SIRT6, localised to mitochondria and nucleus respectively, further support mitochondrial quality control and epigenetic regulation of inflammatory pathways. Collectively, sirtuin pathways offer a molecular nexus linking metabolic dysregulation to structural and functional renal injury in diabetes, and represent promising targets for therapeutic intervention.

Research from Nature Portfolio

Recent studies have elucidated the role of nuclear sirtuin deficits in podocyte health. A seminal work demonstrated that loss of SIRT6 in podocytes exacerbates diabetic proteinuria and foot-process effacement by derepressing Notch1 and Notch4 transcription via increased histone H3K9 acetylation. Podocyte-specific deletion models revealed heightened inflammation and apoptosis, while restoration of SIRT6 reduced expression of urokinase plasminogen activator receptor and stabilised the actin cytoskeleton. Mechanistic insights highlighted SIRT6-mediated epigenetic control as essential to maintaining glomerular filtration barrier integrity in diabetes. These findings establish SIRT6 as a critical gatekeeper against glomerular injury and underscore the therapeutic rationale for epigenetic reprogramming in diabetic kidney disease.

Sirtuin Signaling in Diabetic Kidney Disease publication trend

The graph below shows the total number of articles in sirtuin signaling in diabetic kidney disease across all publications each year (not limited to Nature Index journals).

Technical terms

Sirtuins: A family of NAD+-dependent deacetylases involved in regulating metabolism, stress responses and chromatin structure.

Podocyte: A specialised epithelial cell in the glomerulus essential for preventing protein leakage into urine.

Autophagy: A cellular process for degrading and recycling damaged organelles and proteins to maintain homeostasis.

Histone deacetylation: Removal of acetyl groups from histone proteins, leading to chromatin condensation and transcriptional repression.

Notch signalling: A cell-to-cell communication pathway that regulates gene expression involved in cell differentiation and survival.

References

1. Sirtuins in kidney diseases: potential mechanism and therapeutic targets. Cell Communication and Signaling (2024).
2. Roles of Sirt1 and its modulators in diabetic microangiopathy: A review. International Journal of Biological Macromolecules (2024).
3. SIRT1 Inhibits Transforming Growth Factor β-Induced Apoptosis in Glomerular Mesangial Cells via Smad7 Deacetylation*. Journal of Biological Chemistry (2006).
4. Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes Mellitus. PLOS ONE (2011).
5. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nature Communications (2017).